These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
738 related items for PubMed ID: 17531605
1. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Bahamondes L, Petta CA, Fernandes A, Monteiro I. Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605 [Abstract] [Full Text] [Related]
2. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E Silva JC, Podgaec S, Bahamondes L. Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607 [Abstract] [Full Text] [Related]
4. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis]. Deng S, Lang JH, Leng JH, Liu ZF, Sun DW, Zhu L. Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919 [Abstract] [Full Text] [Related]
7. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D, Schacht E, Wildemeersch P. Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648 [Abstract] [Full Text] [Related]
10. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Bragheto AM, Caserta N, Bahamondes L, Petta CA. Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716 [Abstract] [Full Text] [Related]
12. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Cho S, Nam A, Kim H, Chay D, Park K, Cho DJ, Park Y, Lee B. Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833 [Abstract] [Full Text] [Related]
13. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Ferreira RA, Vieira CS, Rosa-E-Silva JC, Rosa-e-Silva AC, Nogueira AA, Ferriani RA. Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448 [Abstract] [Full Text] [Related]
14. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis]. He SM, Zhang YD. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122 [Abstract] [Full Text] [Related]
15. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study]. Xu XW, Wang LD, Zhu XQ, Yan LZ, Guan YT, Zhu SC, Hu Y. Zhonghua Yi Xue Za Zhi; 2011 Apr 19; 91(15):1047-50. PubMed ID: 21609640 [Abstract] [Full Text] [Related]
18. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S. Fertil Steril; 2011 Feb 19; 95(2):492-6. PubMed ID: 20883991 [Abstract] [Full Text] [Related]
19. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview. Varma R, Sinha D, Gupta JK. Eur J Obstet Gynecol Reprod Biol; 2006 Mar 01; 125(1):9-28. PubMed ID: 16325993 [Abstract] [Full Text] [Related]
20. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Fertil Steril; 2018 Nov 01; 110(6):1129-1136. PubMed ID: 30396557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]